Stay updated with breaking news from Use Authorization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...
U.S. pharmaceutical company Pfizer and its German COVID-19 vaccine partner, BioNTech, announced Thursday recent trials show booster doses of its vaccine effectively protect healthy children ages 5 to 11 from the omicron variant of the coronavirus. In a press release, the companies say their phase-three trials examined data from 140 children ages 5 through 11…
/PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has extended by three months...
MONMOUTH JUNCTION, N.J., April 14, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening con...
The companies plan to apply for US Emergency Use Authorization of a booster dose in the age group in coming days